Coronavirus Replicase-Transcriptase Complex (RTC) (RTC)

The Coronavirus Replicase-Transcriptase Complex (RTC) is a multi-subunit macromolecular machine responsible for the replication and transcription of the viral RNA genome. In coronaviruses like SARS-CoV-2 and HCoV-229E, this machinery is primarily composed of non-structural proteins (nsps) that are cleaved from large polyproteins by viral proteases (MDPI, 2022) [1.1.2]. The core of the RTC is the RNA-dependent RNA polymerase (RdRp, nsp12), which works in conjunction with cofactors nsp7 and nsp8 to synthesize new RNA strands (NIH, 2021) [1.2.1]. Other essential components include the nsp13 helicase, which unwinds RNA duplexes, and the nsp14 exonuclease, which provides a unique proofreading capability that allows coronaviruses to maintain large genomes (Frontiers, 2024) [1.1.4]. Recent research has also identified host factors, such as c-Jun N-terminal kinase (JNK), that interact with the replication machinery by phosphorylating the conserved nucleocapsid (N) protein to regulate viral assembly and RNA synthesis (Brüggemann et al., 2025) [1.1.1]. Because the core components of the RTC are highly conserved across different coronavirus genera, they serve as primary targets for broad-spectrum antiviral drugs. Inhibitors such as remdesivir and molnupiravir target the RdRp to terminate RNA chain elongation or induce lethal mutagenesis, effectively halting viral production in both highly pathogenic and common cold coronaviruses (NIH, 2022) [1.2.2].

Other names

Viral replication machineryCoronavirus replication complexnsp12-nsp7-nsp8 complexRNA-dependent RNA polymerase complexRNA-directed RNA polymerase complex

Inhibition of the RNA-dependent RNA polymerase (RdRp) through premature RNA chain termination or the induction of lethal mutagenesis via nucleoside analog incorporation.